EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Solborn Inc (035610) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Solborn Inc KRW 9,769, price KRW 5,060, upside +93.1%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Industrials · KR · ISIN KR7035610005

SI Some data Sep 24, 2026

Solborn Inc

035610 · KQ

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value 9,769 KRW · Strongly undervalued (+93%)
!Quality 47/100
!Mixed Growth (revenue 5y +8.0 %/yr)
✓Highly profitable · 23.7% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (8/10)
!Moderate moat 63/100
!Evidence only medium, so the estimate is less certain
!Weak on dividend: 19 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

8,650 KRW 2,940 KRW Fair Value 9,769 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 2,940 KRW – 8,650 KRW · fair‑value band 7,739 KRW – 12,858 KRW · the 5,060 KRW price screens below the 9,769 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Solborn in your weekly email

Every Wednesday you see whether Solborn is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services.

Show more

Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and medium-sized enterprises and venture companies. Further, it engages in golf related business and real estate leasing business. The company was formerly known as Serome Technology, Inc. Solborn, Inc. was founded in 1994 and is headquartered in Seoul, South Korea.

Stock analysis

Solborn Inc (035610) currently trades at 5,060 KRW, while our model-based Fair Value estimate is 9,769 KRW, implying the stock looks roughly 48.2% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 12,974 KRW per share, and 10 of the 10 models we run sit above the 5,060 KRW price.

Bear case: the Asset-Based group reads lowest at 5,209 KRW, and 0 of the 10 models stay below the price. Evidence for this calculation is medium.

Scenario range: 7,739 KRW (bear) to 12,858 KRW (bull), the price of 5,060 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 47/100 (below-average quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Solborn Inc reported revenue of 121B KRW in FY2025 versus 100B KRW in FY2021, a compound +4.8%/yr. Reported net income was 20.9B KRW in FY2025, compounding +4.0%/yr from FY2021.

Key figures

Market cap 138B KRW (≈ $102M) · P/S ratio 1.00 · Dividend yield 1.0% · Net margin 17.3% · Return on equity 17.2% · Return on assets (EBIT) 4.0% · Operating margin 10.4% · Revenue (TTM) 131B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 4% below its 52-week high and 55% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 16% fair-value upside, at 93%, 035610 screens cheaper than that median.

Fair Value models

Bear 7,739 KRW Fair Value 9,769 KRW Bull 12,858 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Growth DCF 4,957 KRW 5,892 KRW 7,143 KRW 80
Owner Earnings 7,199 KRW 8,774 KRW 11,019 KRW 78
Residual Income 6,107 KRW 6,491 KRW 7,077 KRW 76
All 10 models by family
DCF Models
Owner Earnings 7,199 KRW 8,774 KRW 11,019 KRW 78
5Y P/E Exit 8,565 KRW 12,896 KRW 17,637 KRW 71
10Y P/E Exit 6,796 KRW 9,680 KRW 12,731 KRW 64
Earnings-Based
Graham-Dodd 5,189 KRW 9,701 KRW 12,046 KRW 66
Multiples
P/E Multiple 12,592 KRW 16,789 KRW 20,987 KRW 63
P/B Multiple 9,730 KRW 12,974 KRW 16,217 KRW 55
Asset-Based
NCAV (Graham) 3,887 KRW 5,209 KRW 7,775 KRW 54
Growth DCF
Growth DCF 4,957 KRW 5,892 KRW 7,143 KRW 80
Rev-Margin DCF 6,790 KRW 9,911 KRW 13,492 KRW 73
Economic Profit
Residual Income 6,107 KRW 6,491 KRW 7,077 KRW 76

Open the full fair value analysis →

Notify me when 035610 reaches fair value

Put 035610 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 47/100

Of which business quality 48 · Market factors (momentum, volatility) 74

Profitability 43
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 55
Earnings quality: real cash, not paper profit
Fin. Strength 77
Balance sheet, leverage, solvency risk
Investment 35
Disciplined investing over empire-building
Low Volatility 68
Calm price path (market factor)
Momentum 78
Price trend over the last 3–12 months (market factor)
52W Momentum 73
Distance to the 52-week high (market factor)
Net Issuance 38
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 80/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−1.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.0%
Start year 2020 (pandemic). Over 10 years: +5.5% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+22.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+21.4%
Dividend (yield on the price)1.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.62% vs 48%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 20%
Start year 2020 (pandemic)

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.

Watch 035610, get fair value alerts →

Compare Solborn Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 378 stocks

Beats the industry median on 7/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 47 · Below median
Fair Value upside +93% · Top 25%
Profitability
Return on equity (TTM) 17% · Top 25%
Return on assets 6% · Top 25%
Net margin (TTM) 24% · Top 25%
Operating margin (TTM) 10% · Above median
Growth and dividend
Revenue growth 42% · Top 25%
Dividend yield (TTM) 1.0% · Below median

Valuation Multiplesvs Conglomerates median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 33
FUTURE (revenue growth)100 · sector 16
PAST (return on equity)69 · sector 19
HEALTH (low debt)100 · sector 89
DIVIDEND (yield)19 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
3M Company MMM $170.30 $71.86 −58%
Honeywell International Inc HON $211.79 $244.82 +16%
CITIC Limited 0267 HK$13.08 HK$26.16 +100%
Poste Italiane S.p.A PST €25.71 €9.10 −65%
Swire Pacific Limited 0019 HK$102.80 HK$28.34 −72%
CK Hutchison Holdings 0001 HK$67.60 HK$135.20 +100%
SK Inc 034730 611,000 KRW 351,594 KRW −42%
Jardine Matheson Holdings J36 $57.30 $79.11 +38%
Kingboard Holdings 0148 HK$55.55 HK$85.25 +53%
SGH Limited SGH A$36.69 A$42.47 +16%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Solborn Inc Fair Value". https://www.fairvalue-calculator.com/stock/035610

Frequently asked questions

Is Solborn Inc (035610) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 9,769 KRW versus a price of 5,060 KRW, about +93% upside (undervalued).
What is the fair value of 035610?
Our model-based fair value for Solborn Inc is 9,769 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 5,060 KRW.
What is the quality score of 035610?
Solborn Inc has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Solborn Inc (035610)?
Our model-based price target is the fair value of 9,769 KRW (as of Sep 24, 2026) from 10 valuation models. Cautious scenario 7,739 KRW, optimistic scenario 12,858 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Solborn Inc stock forecast for 2026?
Our models put fair value at 9,769 KRW, about +93% upside versus a price of 5,060 KRW (undervalued). Cautious scenario 7,739 KRW, optimistic scenario 12,858 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Solborn Inc (035610)?
Solborn Inc reported trailing-twelve-month revenue of about 131B KRW (latest available figure, as of Sep 24, 2026).
Does Solborn Inc pay a dividend?
Solborn Inc currently shows a dividend yield of about 0.95% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Solborn Inc (035610)?
For today's price to be fair in a discounted-cash-flow model, Solborn Inc would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 035610 use?
Our models discount Solborn Inc at 12.4 %: a base by market capitalisation (micro), damped by beta 0.76, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Solborn Inc that is less than minus 40 % per year a year over ten years, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Solborn Inc (035610) delivered so far?
Over the past 5 years revenue at Solborn Inc grew +8.0 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Solborn Inc (035610) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Solborn Inc (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Solborn Inc (035610)?
The free-cash-flow yield on the price is 10.51 %: that much free cash flow Solborn Inc produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Solborn Inc (035610)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Solborn Inc it is 9,769 KRW per share (as of Sep 24, 2026), against a price of 5,060 KRW. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Solborn Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 035610 trades below its calculated fair value: price 5,060 KRW, fair value 9,769 KRW, a gap of about +93% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 035610?
No. The price is what the market pays today (5,060 KRW); the fair value is what the company's own numbers justify (9,769 KRW). For Solborn Inc the two are 4,709 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Solborn Inc worth?
The market values Solborn Inc at about 138B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 5,060 KRW; our models calculate a fair value of 9,769 KRW per share.
What do the bullish and bearish scenarios say about 035610?
Our models span a range for Solborn Inc: cautious scenario 7,739 KRW, base 9,769 KRW, optimistic 12,858 KRW per share (as of Sep 24, 2026, price 5,060 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Solborn Inc (035610)?
Balance-sheet figures for Solborn Inc (as of Sep 24, 2026): return on equity 17.2%. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is 035610 from its 52-week high?
Solborn Inc trades at 5,060 KRW, about 4% below its 52-week high of 5,290 KRW and 55% above the low of 3,255 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 9,769 KRW is for.
Which stocks are comparable to Solborn Inc?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, CITIC Limited, Poste Italiane S.p.A, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Solborn Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 5,060 KRW, calculated fair value 9,769 KRW (+93%), Quality Score 47/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 035610 calculated?
We run Solborn Inc through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 9,769 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Solborn Inc currently trades 93 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Solborn Inc (035610)?
The closing price on Sep 23, 2026 was 5,060 KRW. Our model-based fair value is 9,769 KRW, about +93% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Solborn Inc right now?
The price is below even our cautious bear case (7,739 KRW). The market is more pessimistic than our downside scenario. Solid quality (47/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of Solborn Inc

How large is the market capitalisation of Solborn Inc (035610)?
The market capitalisation of Solborn Inc is 138B KRW (≈ $102M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Solborn Inc (035610)?
The price-to-sales ratio of Solborn Inc is 1.00 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Solborn Inc (035610)?
The dividend yield of Solborn Inc is 1.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Solborn Inc (035610)?
The net margin of Solborn Inc is 17.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Solborn Inc (035610)?
The return on equity (ROE) of Solborn Inc is 17.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Solborn Inc (035610)?
On an EBIT basis the return on assets of Solborn Inc is 4.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Solborn Inc (035610)?
The operating margin of Solborn Inc is 10.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Solborn Inc (035610)?
Revenue at Solborn Inc is growing +42.2% versus a year earlier (3y avg +8.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Solborn Inc (035610)?
Earnings per share at Solborn Inc are growing +482% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch Solborn Inc in the live analysis

One click puts Solborn Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.